Immune cells and the trajectories of depression, anxiety, and cognitive function among people with amyotrophic lateral sclerosis
Authors:
Open Access
- 22 November 2024
- journal article
- research article
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 42, 100907
Abstract
No abstract availableKeywords
Funding Information
- CDC (R01TS000324-01-00)
- European Research Council (802091)
- European Research Council
- Swedish Research Council (2023-02428)
This publication has 40 references indexed in Scilit:
- Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc StudyJournal of Neurology, 2024
- Repeated cognitive assessments show stable function over time in patients with ALSJournal of Neurology, 2024
- Blood Th17 cells and IL‐17A as candidate biomarkers estimating the progression of cognitive impairment in stroke patientsJournal of Clinical Laboratory Analysis, 2022
- The impact of stress on immune systems and its relevance to mental illnessNeuroscience Research, 2022
- Prevalence of depression among amyotrophic lateral sclerosis (ALS) patients: A systematic review and meta-analysisJournal of Affective Disorders, 2021
- Cognitive and behavioural impairment in amyotrophic lateral sclerosis: A landmark of the disease? A mini review of longitudinal studiesNeuroscience Letters, 2021
- Brain-immune crosstalk in the treatment of major depressive disorderEuropean Neuropsychopharmacology, 2021
- An Act of Balance Between Adaptive and Maladaptive Immunity in Depression: a Role for T LymphocytesJournal of Neuroimmune Pharmacology, 2015
- Is there a role for immune-to-brain communication in schizophrenia?Psychopharmacology, 2015
- T-helper-1 and T-helper-2 Responses in Psychiatric DisordersBrain, Behavior, and Immunity, 2001